Phase 1/2 study of FOG-001 in participants with locally advanced or metastatic solid tumors.

Disease:

Cancer, Colorectal Cancer, Solid Tumor, Locally Advanced Solid Tumor, Metastatic Cancer, WNT Pathway, β-catenin, Beta-catenin, Adenomatous Polyposis Coli, APC, HCC, Desmoid, Microsatellite Stable Colorectal Cancer, Metastatic Castration-resistant Prostate Cancer, FAP, Endometrial Carcinoma, Prostate Cancer, Microsatellite Instability-High Colorectal Cancer, CTNNB1, Adamantinomatous Craniopharyngioma

Study phase:

Physician name:

Jordi Rodon Ahnert

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-888-994-0731